|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net income (loss) | |||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||
| Depreciation and amortization expense | |||
| Stock-based compensation expense | |||
| Amortization of common stock warrants | |||
| Amortization and remeasurement of common stock issuable pursuant to subscription agreement | |||
| Impairments of long-lived assets and other assets | |||
| Provision for bad debts | |||
| Amortization of operating lease right-of-use assets | |||
| Deferred income taxes | |||
| Other | |||
| Changes in operating assets and liabilities, net of effects of business acquisitions: | |||
| Accounts receivable | |||
| Prepaid expenses and other assets | |||
| Accounts payable | |||
| Accrued and other current liabilities | |||
| Deferred revenue | |||
| Operating lease liabilities | |||
| Other long-term liabilities | |||
| Net cash provided by operating activities | |||
| INVESTING ACTIVITIES | |||
| Purchases of marketable securities | |||
| Maturities of marketable securities | |||
| Purchases of property and equipment, including capitalized internal-use software | |||
| Purchases of patents | |||
| Acquisitions of businesses, net of cash acquired | |||
| Other investing activities | |||
| Net cash provided by (used in) investing activities | |||
| FINANCING ACTIVITIES | |||
| Proceeds from the issuance of common stock upon initial public offering, net of underwriting discounts | |||
| Proceeds from the issuance of Series A redeemable convertible preferred stock | |||
| Redeemable Convertible Preferred Stock | |||
| Series A Redeemable Convertible Preferred Stock | |||
| Total proceeds from the issuance of Series A redeemable convertible preferred stock | |||
| Taxes paid related to net share settlement of equity awards | |||
| Proceeds from exercise of stock options | |||
| Proceeds from exercise of common stock warrants | |||
| Changes in advances from payment card issuer | |||
| Proceeds from modification of common stock warrants | |||
| Proceeds from the issuance of non-voting common stock | |||
| Deferred offering costs paid | |||
| Repurchases of common stock | |||
| Net cash used in financing activities | |||
| Effect of foreign exchange on cash, cash equivalents, and restricted cash and cash equivalents | |||
| Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents | |||
| Cash, cash equivalents, and restricted cash and cash equivalents - beginning of period | |||
| Cash, cash equivalents, and restricted cash and cash equivalents - end of period | |||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | |||
| Cash paid for income taxes, net of tax refunds | |||
| SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES | |||
| Stock-based compensation capitalized as internal-use software | |||
| Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering | |||
| Reclassification of deferred offering costs to additional paid-in capital upon initial public offering | |||
| Fair value of contingent consideration in connection with a business combination | |||
| Changes in accrued purchases of property and equipment, including capitalized internal-use software | |||
| Deferred offering costs not yet paid | |||
| Accretion of Series A redeemable convertible preferred stock | |||
| Series A Redeemable Convertible Preferred Stock | |||
| Total accretion of Series A redeemable convertible preferred stock | |||
| Issuance of non-voting common stock in connection with business acquisitions | |||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION RELATED TO LEASES | |||
| Cash paid for amounts included in the measurement of operating lease liabilities | |||
| Lease liabilities arising from obtaining right-of-use assets | |||
| Remeasurement of operating lease right of use assets | |||
| RECONCILIATION OF CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AND CASH EQUIVALENTS TO THE CONSOLIDATED BALANCE SHEETS | |||
| Cash and cash equivalents | |||
| Restricted cash and cash equivalents, current | |||
| Restricted cash and cash equivalents, noncurrent |
Loading...